A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TNSS / total nasal symptom score

[Related PubMed/MEDLINE]
Total Number of Papers: 191
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TNSS  (>> Co-occurring Abbreviation)
Long Form:   total nasal symptom score
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A novel device combining acoustic vibration with oscillating expiratory pressure for the treatment of nasal congestion. NOSE, PNIF, VAS
2020 A preliminary report on the effect of gabapentin pretreatment on periprocedural pain during in-office posterior nasal nerve cryoablation. PNN, VAS
2020 A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis. AHI, OSA, RDI
2020 Artemisia annua-sublingual immunotherapy for seasonal allergic rhinitis: A randomized controlled trial. AEs, CST1, PPP, SAR, SLIT
2020 As-needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients With Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. FF, INCS, NPIF, PAR, RCQ-36
2020 Clinical symptoms and biomarkers of Bermuda grass-induced allergic rhinitis using the nasal allergen challenge model. AR, NAC
2020 Compliance, efficacy, and safety of subcutaneous and sublingual immunotherapy in children with allergic rhinitis. AEs, AR, NHD, RMS, SCIT, SLIT, SMS
2020 Correlation of Nasal Fluid Biomarkers and Symptoms in Patients with Persistent Allergic Rhinitis. ARIA, CC16, ELISA, IL-5, NALF, PAR
2020 Double-Blind Placebo-Controlled Trial of Bepotastine Salicylate in Patients With Allergic Rhinitis. PAR
10  2020 Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps. CRSwNP, nasal drop, SNOT-22
11  2020 Effects and safety of intranasal phototherapy for allergic rhinitis: Study protocol for a single-center, randomized, double-blind, parallel, placebo-controlled, investigator-initiated, pilot study. AR, IgE, RCTs, RQLQ
12  2020 Effects and safety of intranasal phototherapy for allergic rhinitis: Study protocol for a single-center, randomized, parallel (acupuncture-controlled), open-label, investigator-initiated, pilot study. AR, IgE, RCTs, RQLQ
13  2020 Effects of self-prepared hypertonic nasal saline irrigation in allergic rhinitis: A randomized controlled trial. AR
14  2020 Efficacy and safety of two Ayurvedic dosage forms for allergic rhinitis: Study protocol for an open-label randomized controlled trial. AR, TMD12
15  2020 Efficacy of Acupuncture at the Sphenopalatine Ganglion in the Treatment of Persistent Allergic Rhinitis. PAR, RQLQ, SPG
16  2020 Elevated Serum Level of CD48 in Patients with Intermittent Allergic Rhinitis. FeNO, IAR, NLR, sCD48
17  2020 Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial. AR, ARM, RQLQ
18  2020 Injection of Steroid in Nasal Polyps: A Systematic Review. CRS, TNPS
19  2020 Laser ablation of posterior nasal nerves for rhinitis. PNN, RF
20  2020 Local Expression of Mucosal YKL-40; Correlation of YKL-40 with Clinical Manifestations and Immunopathogenesis of Moderate/Severe Persistent Allergic Rhinitis Patients. ---
21  2020 Low serum 25-hydroxyvitamin D levels are associated with perennial allergic rhinitis but not disease severity. AR, PAR
22  2020 Probiotic NVP-1703 Alleviates Allergic Rhinitis by Inducing IL-10 Expression: A Four-week Clinical Trial. AR, RCAT
23  2020 Relationship between nasal mucociliary clearance and disease severity in children with allergic rhinitis: A comparative cross-sectional study. MCC, NMCCT, VAS
24  2020 Specific sublingual immunotherapy in children with perennial rhinitis: a systemic review and meta-analysis. AEs, AR, HDM, PAR, RR, SLIT, SMD, TMS
25  2020 The influence of nasal bacterial microbiome diversity on the pathogenesis and prognosis of chronic rhinosinusitis patients with polyps. CRSsNP, CRSwNP
26  2020 The role of oral vitamin D3 supplementation in the treatment of Chronic Rhinosinusitis in adults with Vitamin D deficiency. CRS
27  2019 A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. AERD
28  2019 An External CAM Therapy (Tian Jiu) versus Placebo in Treatment of Allergic Rhinitis: A Pilot Single-Blinded, Three-Arm, Randomized Controlled Study. AR, CAM, QOL, RMS, RQLQ, TJ
29  2019 Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial. AR, BMF, LSQDS, VAS
30  2019 Cold dry air provocation is a reliable diagnostic tool in nonallergic rhinitis. CDA, MCA, NAR, NHR, ROC, TNR, TNV
31  2019 Comparison of Long-term Efficacy of Subcutaneous Immunotherapy in Pediatric and Adult Patients With Allergic Rhinitis. AR, DMS, HDM, QOL, SCIT, TCS
32  2019 Differential Expression of Fas in Moderate/Severe and Mild Persistent Allergic Rhinitis and Its Correlation With Pathological Parameters. M PAR
33  2019 Efficacy and safety of sublingual dust mite drops in children with mono- or polysensitized allergic rhinitis. HDM, IgE, IL, TGF-beta1
34  2019 Efficacy of Bimin decoction for patients with perennial allergic rhinitis: an open-label non-inferiority randomized controlled trial. AR, BMD, LQDCS, RQLQ
35  2019 Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study. ECC
36  2019 Immunologic modification in mono- and poly-sensitized patients after sublingual immunotherapy. HDM, SLIT
37  2019 Long non-coding RNA antisense non-coding RNA in the INK4 locus expression correlates with increased disease risk, severity, and inflammation of allergic rhinitis. AR, IL, INSS, lncRNA
38  2019 Prescription Profile and Clinical Outcomes in Patients with Allergic Rhinitis Treated with Oral Antihistamines or Nasal Corticosteroids. ---
39  2019 Risk factors analysis of attention deficit/hyperactivity disorder and allergic rhinitis in children: a cross-sectional study. ADHD, AR, IHS, PRQLQ, SNAP-IV
40  2019 Sensitization to Cat: When Is Nasal Challenge Needed? AIT, cNCT, NEo, PEF, PER, PNIF, SPT
41  2019 The relationship between IL-17A and IL-22 expression and clinical severity in patients with moderate/severe persistent allergic rhinitis. AR, IHC, M PAR, PAR, RT-PCR, sIgE, tIgE
42  2019 Vitamin D: A Modulator of Allergic Rhinitis. TEC
43  2019 [Changes of serum miR-375 and blood target genes in patients with allergic rhinitis before and after treatment and its significance]. AR, IL-10, IL-13, IL-6, JAK2, STAT3, TNF-alpha
44  2018 A randomized controlled trial comparing a xyloglucan-based nasal spray with saline in adults with symptoms of rhinosinusitis. ---
45  2018 Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study. HDM, LCN2, SLIT
46  2018 Correlation of microRNA profiles with disease risk and severity of allergic rhinitis. AR, AUC, DEMs, INSS, miRNA, PCA, ROC
47  2018 Differential expression of CCL18 in moderate/severe and mild persistent allergic rhinitis and its correlation with disease parameters. M/S, PAR
48  2018 Effect of a Novel Photoelectrochemical Oxidation Air Purifier on Nasal and Ocular Allergy Symptoms. CI, PECO, TOSS, TSS
49  2018 Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinitis. LSM
50  2018 Evaluation of allergic rhinitis with nasal symptoms and nasal mucociliary clearance in patients with fibromyalgia syndrome. AR, FM, NMC, STT
51  2018 Evaluation of Montelukast for the Treatment of Children With Japanese Cedar Pollinosis Using an Artificial Exposure Chamber (OHIO Chamber). AEs, JC
52  2018 Evaluation of olfactory function in children with seasonal allergic rhinitis and its correlation with acoustic rhinometry. CCCRC, SAR
53  2018 Glucocorticoid-Induced Transcription Factor 1 (GLCCI1) Variant Impacts the Short-Term Response to Intranasal Corticosteroids in Chinese Han Patients with Seasonal Allergic Rhinitis. ABCB1, GLCCI1, INCS, SAR, TBX21, TOSS, VAS
54  2018 Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit. AR, EEU, SLIT-T, TOSS, TRSS
55  2018 Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber. INFP, LORA, TOSS, VAS
56  2018 Phase 1 pharmacokinetics and phase 3 efficacy of testosterone nasal gel in subjects with seasonal allergies. ACC, AR, AUC, PK, sTT, TNG
57  2018 Repeatability of nasal allergen challenge results: Further validation of the allergic rhinitis clinical investigator collaborative protocols. NAC, PNIF
58  2018 The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy. AR, AR-CIC, Cat-PAD, NAC, PNIF
59  2018 The Relationship between Serum Vitamin D Levels with Allergic Rhinitis Incidence and Total Nasal Symptom Score in Allergic Rhinitis Patients. AR, ECLIA
60  2018 Treatment of persistent allergic rhinitis via acupuncture at the sphenopalatine acupoint: a randomized controlled trial. PAR, RQLQ, SPA, SPG
61  2018 [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in children with allergic rhinitis and the change of TGF-beta and IL-13 mRNA level]. AR, SLIT, TMS
62  2018 [Long-term efficacy of house dust mite subcutaneous immunotherapy in allergic rhinitis patients]. AR, HDM, RQLQ, SCIT
63  2017 A randomized, double-blind, placebo controlled trial of sublingual immunotherapy with house-dust mite extract for allergic rhinitis. ACS, AE, AR, HDM, MS, SLIT
64  2017 Botolinum toxin in rhinitis: Literature review and posterior nasal injection in allergic rhinitis. AR, BTX, RQLQ
65  2017 Control of Allergic Rhinitis and Asthma Test for Children (CARATKids): Validation in Brazil and cutoff values. C-ACT, MCID, VAS
66  2017 Cryosurgical posterior nasal tissue ablation for the treatment of rhinitis. PNN
67  2017 Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid. AEC, AEs, ICT, LPR, P. pratense, TU
68  2017 Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial. ---
69  2017 Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study. PAR
70  2017 Food allergy and allergic rhinitis in 435 asian patients - A descriptive review. ---
71  2017 Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trial. ADRs, AEs, PAR, TOSS, TSS
72  2017 Management of Intractable Nasal Hyperreactivity by Selective Resection of Posterior Nasal Nerve Branches. AR, SPA
73  2017 Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis. AR, ASIT, HDMs, PBMCs, SCIT, SLIT, TMS
74  2017 Technical and clinical validation of the Allergen BioCube for timothy grass. AR, NIS, PEFR, PNIF
75  2017 The efficacy and safety of sublingual immunotherapy in children and adult patients with allergic rhinitis. AEs, AR, Der f, HDM, SLIT, TMS, VAS
76  2017 Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber). BIL, FEX
77  2017 Three-dimensional image analysis for staging chronic rhinosinusitis. Chicago MLM, CRS, LM, SNOT-22
78  2017 [Efficacy and safety of endonasal phototherapy in the treatment of adult allergic rhinitis: A Meta-analysis]. CI, OR, RCT, RQLQ, WMD
79  2017 [Moderate and severe persistent allergic rhinitis treated with acupoint application therapy of the different intensity: a randomized controlled trial]. EOS, RQLQ
80  2016 Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU). CACF, EEU, PNIF, TRSS
81  2016 Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial. AR
82  2016 Comparison of efficacy, safety, and cost-effectiveness of rupatadine and olopatadine in patients of allergic rhinitis: A prospective, randomized, double-blind, parallel group study. AR
83  2016 Effect of Inhalation of Aromatherapy Oil on Patients with Perennial Allergic Rhinitis: A Randomized Controlled Trial. CFS, PAR, RQLQ, VSH
84  2016 Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial. AR, RCT
85  2016 Efficacy of the novel nasal steroid S0597 tested in an environmental exposure unit. EEU, SAR
86  2016 Expression of leukotriene and its receptors in eosinophilic chronic rhinosinusitis with nasal polyps. CRSwNP, CysLT1R, CysLT2R, ECRS, LT, LTC4, LTR, LTRA, mRNA, non-ECRS, qRT-PCR
87  2016 Histamine antagonist Bepotastine suppresses nasal symptoms caused by Japanese cedar and cypress pollen exposure. D-CAT
88  2016 Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. AIT, SPT, TOSS
89  2016 Method for a homogeneous distribution of pollens in an environmental exposure chamber. EECs
90  2016 Safety, efficacy and repeatability of a novel house dust mite allergen challenge technique in the Fraunhofer allergen challenge chamber. HDM
91  2016 Short Time Efficiency of Rhinophototherapy in Management of Patients with Allergic Rhinitis Resistant to Medical Therapy. AD, AR, GSS, RQLQ
92  2016 The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration. AEs, AR, Der f, HDM, RQLQ, SLIT, VAS
93  2016 The influence of house dust mite sublingual immunotherapy on the TSLP-OX40L signaling pathway in patients with allergic rhinitis. AR, ELISA, HDM, INSS, mRNA, PBMCs, qRT-PCR, SLIT, Th2
94  2016 [Development and Evaluation of Allergic Rhinitis-Specific Quality of Life (ARSQOL) Scale for Adults]. ARSQOL, CVI
95  2016 [Efficacy and economic evaluation of sublingual immunotherapy with Dermatophagoides farinae drops in patients with allergic rhinitis and allergic asthma]. DASS, NASS, SLIT, TAMS, TRMS
96  2016 [Efficacy of sublingual immunotherapy in children with allergic rhinitis]. TMS, VAS
97  2015 A comparison of fluticasone propionate nasal spray and cetirizine in ragweed fall seasonal allergic rhinitis. FPNS
98  2015 Assessing the efficacy of a novel temperature and humidity control machine to minimize house dust mite allergen exposure and clinical symptoms in allergic rhinitis children sensitized to dust mites: a pilot study. AR, ELISA, RH
99  2015 Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU). AR, EEU, PNIF, TSS
100  2015 Computer-assisted staging of chronic rhinosinusitis correlates with symptoms. CRS, LM, MLM